shares wellcome plc fell sharply following report bristol myers would seek food and drug administration permission test its aids vaccine humans end march dealers said wellcome shares slumped quoted low 453p report after yesterday 496p close but later rose 464p earlier this month wellcome spokesman said company was applying for licences and several major countries for its retrovir drug which can used for treatment aids department health and social security has already issued marketing licence for retrovir reuter 